Stockhldr:
It appeared imminent to me from the onset of DNAPrint's emergence and development as the true visionary of pharmacogenomics, theranostics, and all-around biotechnology achievements...and that's when I made my initial comments. Tony Frudakis deserves accolades beyond multi-achievements at every developmental stage of DNAPrint. Let's not forget the Management, CEO Richard Gabriel, etc., who have also endeavored multiple-business tasks in behalf of the shareholders, in my viewpoint, in gratitude to a remarkable management staff! - That is MHO! If the high status operations change, I will be the first to deny...otherwise...Let's Roll!!
Ann
News 
Market Data 
Discover 
AI
